Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Repligen (RGEN) Tops Q3 EPS by 12c, Revenues Beat; Offers FY20 EPS/Revenue Guidance Above Consensus
November 5, 2020 7:47 AM ESTRepligen (NASDAQ: RGEN) reported Q3 EPS of $0.40, $0.12 better than the analyst estimate of $0.28. Revenue for the quarter came in at $94.1 million versus the consensus estimate of $86.45 million.
Reports record quarterly revenue of $94.1 million with strong margin expansionOverall revenue grew 35% year-over-year, with organic growth of 31%Raises revenue guidance to $348-$352 million and overall revenue growth to 29%-30% for full year 2020, representing 23%-24% organic growthCompletes acquisition of Non-Metallic Solutions and announces agreement to acquire bioprocess systems innovator ARTeSYN BiosolutionsTony J. Hunt, President and Chief Executive Officer said, We are... More
